Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Metabolic Dysfunction After Initiation of Androgen Receptor Pathway Inhibitors in Prostate Cancer.
Journal: JAMA oncology
Published: August 13, 2026
Axitinib-Pembrolizumab and Adverse Event Management in Patients With Advanced Renal Cell Carcinoma.
Journal: JAMA network open
Published: May 21, 2026
A Prolonged Nightly Fasting Plus Telehealth Coaching Intervention (PNF+) for Men on Androgen Deprivation Therapy for PCa: A Pilot Feasibility Randomized Controlled Trial.
Journal: Nutrients
Published: February 23, 2026
Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castrate-resistant prostate cancer: a pooled analysis.
Journal: The oncologist
Published: February 22, 2026
Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis.
Journal: The oncologist
Published: February 22, 2026
The path forward for T cell engagers in patients with prostate cancer.
Journal: Journal for immunotherapy of cancer
Published: February 09, 2026
Assessing the Feasibility of a Self-Management Intervention for Individuals With Advanced Prostate Cancer and Comorbid Type II Diabetes Mellitus.
Journal: Cancer medicine
Published: January 26, 2026
CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate Cancer.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Risk of fracture following androgen receptor pathway inhibitors in men with advanced prostate cancer.
Journal: Journal of the National Cancer Institute
Published: October 22, 2025
A phase 1, first-in-human, dose escalation study of JNJ-80038114, a PSMAxCD3 bispecific antibody, in participants with metastatic castration-resistant prostate cancer.
Journal: Cancer chemotherapy and pharmacology
Published: August 26, 2025
Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes.
Journal: Prostate cancer and prostatic diseases
Published: August 12, 2025
Molecular alteration profiles characterize intraductal carcinoma of the prostate.
Journal: Cancer
Published: August 07, 2025
Last Updated: 09/26/2026